key: cord-1055720-jklq9jz4
authors: Yun, Jun Seop; Kim, Nam Hee; Song, Hyeeun; Cha, So Young; Hwang, Kyu Ho; Lee, Jae Eun; Jeong, Cheol-Hee; Song, Sang Hyun; Kim, Seonghun; Cho, Eunae Sandra; Kim, Hyun Sil; Yook, Jong In
title: Emergence of glycogen synthase kinase-3 interaction domain enhances phosphorylation of SARS-CoV-2 nucleocapsid protein
date: 2022-01-25
journal: bioRxiv
DOI: 10.1101/2022.01.24.477037
sha: 3760cae35f41420b966acd10be2c0c2c53d2438d
doc_id: 1055720
cord_uid: jklq9jz4

A structural protein of SARS-CoV-2, nucleocapsid (N) protein is abundantly expressed during viral replication. The N protein is phosphorylated by glycogen synthase kinase (GSK)-3 on the serine/arginine (SR) rich motif located in disordered regions. Although phosphorylation by GSK-3β constitutes a critical event for viral replication, the molecular mechanism underlying N phosphorylation is not well understood. In this study, we found the putative alpha-helix L/FxxxL/AxxRL motif known as the GSK-3 interacting domain (GID), commonly found in many endogenous GSK-3β binding proteins, such as Axins, FRATs, WWOX and GSKIP. Indeed, N interacts with GSK-3β similarly to Axin, and Leu to Glu substitution of the GID abolished the interaction, with loss of N phosphorylation. Unlike with endogenous GID proteins, the N interaction neither disturbs endogenous GSK-3 activity nor regulates subsequent canonical Wnt activity and the Snail-EMT program. Notably, N abundance in SARS-CoV-2 is incomparably high compared to other coronaviruses, such as 229E, OC43 and HKU1. Compared to other coronaviruses, N harbors a CDK1 primed phosphorylation site and Gly-rich linker for enhanced phosphorylation by GSK-3β. Furthermore, we found that the S202R mutant found in Delta and R203K/G204R mutant found in the Omicron variant allows increased abundance and hyper-phosphorylation of N. Our observations suggest that the emergence of GID and mutations for increased phosphorylation in N may have contributed to the emergence of SARS-CoV-2 and evolution of variants, respectively. Further study, especially in a BSL3-equipped facility, is required to elucidate the functional importance of GID and N phosphorylation in SARS-CoV-2 and variants.

The N protein is the most abundantly expressed structural protein during viral replication of SARS-CoV-2 (1) . In addition to its structural role in the ribonucleoprotein complex in virion, the N protein plays key roles in viral RNA and protein synthesis, packaging, and envelope formation (2, 3) . Although the spike protein is only used as an immunogen in current vaccines, serological antibodies against N protein can be used for detection of early and previous infection (4, 5) . The highly basic N protein of coronavirus consists of about 400 amino acids (~ 50kDa) with three distinct domains.

Structured N-terminal and C-terminal domains play diverse roles in multimerization and RNA binding (3) . The central disordered region harbors the Ser/Arg (SR)-rich motif, which is highly conserved in other coronaviruses, such as OC43, HKU1 and MERS.

Interestingly, the SR-rich motif of coronavirus is phosphorylated by GSK-3, and GSK-3 inhibitors suppress viral replication in Vero cells (6, 7) . GSK-3 inhibition also selectively reduces genomic RNA and long subgenomic mRNA (8) , and a clinical trial with a GSK-3 inhibitor, lithium, yielded reduced risk of SARS-CoV2 (9) . Crucially, a recent study revealed that N mutations around the SR-rich motif found in SARS-CoV-2 variants allows significantly increased viral replication compared with ancestral Wuhan Hu-1 N protein (10) . These results indicate the importance of N phosphorylation by GSK-3 during viral replication and mutational evolution of coronavirus although the underlying molecular mechanism is unclear.

GSK-3 is an endogenously abundant kinase which plays a key role in many signaling pathways, including Wnt signaling. In the Wnt pathway, GSK-3 is recruited to a multiprotein complex with adenomatous polyposis coli (APC) and scaffolding protein Axin (11, 12) . Axin directly binds to GSK-3, resulting in inhibition of the kinase activity and 5 regulation of canonical Wnt activity (13) . Crystallography of GSK-3 and Axin peptide reveals that hydrophobic helical ridges formed by Axin residues of Phe388, Leu392, Leu396 in GID pack into the helical groove of the 285-299 loop in GSK-3 (14) . This interacting domain is also found in other GSK-3 interacting proteins, such as FRATs, GSK-3 interacting protein (GSKIP), and WWOX (15, 16) . The GID in many proteins provides diverse functions for GSK-3 and its substrate. For example, multi-protein complex of APC and GSK-3 enhances β-catenin phosphorylation and Axin-GSK3 binding provides nuclear export of GSK-3 stabilizing, epithelial-mesenchymal transition (EMT)-inducer Snail in cancer (14, 17) . The typical amino acids in helical GID consist of L/FxxxL/AxxRL (Fig. 1A) . In this study, we found GID located next to the SR-rich domain of N protein in SARS-CoV-2 (hereafter N), critical for N protein phosphorylation, suggesting that interaction between N and GSK-3 plays a critical role in viral replication and evolution of SARS-CoV-2. Compared to N protein in other nonpathogenic coronaviruses, N protein of SARS-CoV-2 also harbors a CDK1 phosphorylation site and a flexible linker between GID and the SR-rich region, allowing enhanced phosphorylation of N. Further, we found that N mutations in Delta and Omicron variants provide enhanced phosphorylation and increased abundance of N. 6 

Phosphorylation of many endogenous and viral proteins by GSK-3 is dependent on GSK-3 binding of protein-protein interaction (14, 18) . In turn, GSK-3 interacting domain (GID) embedded in GSK-3 substrate provides efficient self-phosphorylation. Because N of coronavirus is phosphorylated by GSK-3 (6,7), we examined whether GID provides N-GSK-3 interaction and efficient phosphorylation, finding a L/FxxxLxxRL motif in the unstructured disordered region of ancestral Wuhan Hu-1 N protein (Fig.   1A ). The amino acid sequence of GID is highly conserved in many GSK-3 interacting proteins, such as AXINs, GSKIP and WWOX. Because the hydrophobic residues in GID play a critical role in GSK-3 interaction (14, 19, 20) , we generated Lue to Glu substitution mutants (L223/227E) from ancestral SARS-CoV-2 N protein. We next transfected them with HA-tagged GSK-3β (hereafter GSK-3) and N expression vectors in 293 cells and performed immunoprecipitation assay to examine interaction between N and GSK-3. Indeed, N protein interacts with GSK-3 and point mutant of hydrophobic residues in N-GID, largely abolishing the interaction with GSK-3, although protein abundance of N and mutants was comparable (Fig. 1B) . To further determine the role of N-GSK-3 interaction, we next examined the phosphorylation status of N and mutants by means of mobility shift on a Phos-tag gel. Interestingly, mutation of hydrophobic residue(s) largely decreased phosphorylation of N (i.e., increased mobility shifts in phos-tag gel) without affecting its stability (Fig. 1C) . Interestingly, GID mutation in Axin2 scaffolding protein largely abolished Axin2 phosphorylation along 7 with protein abundance (Fig. S1A) (21) . To further determine the phosphorylation status of N and its mutants, we treated it with lambda protein phosphatase (λ PPase) and subjected it to phos-tag gel. The λ PPase treatment increased mobility shift of N and point mutant of L223 or L227, while the L223/227 mutation was unaffected (Fig.   1D ). Interestingly, mobility shift of N-L223/227E mutant was not affected by λ PPase treatment, suggesting that GID provides the main N phosphorylation. In a repeated experiment, we noted that N was hardly de-phosphorylated by λ PPase, while those mutants were dephosphorylated under the same experimental condition, suggesting N oligomerization by phosphorylation. To simply examine this possibility, we generated an N-EGFP fusion construct and co-transfected it with either Flag-tagged N or L223/227E mutant in 293 cells. Immunoprecipitation assay revealed that Flag-N interacts with N-EGFP, while N and L223/227E mutant interaction decreased (Fig. 1E ).

Immunofluorescence also supported the co-localization of N and GSK-3, especially in condensate-like structures in the cytosolic space, as compared to L223/227E mutant N (Fig. 1F ). Our observations indicate that N in SARS-CoV-2 harbors GID, providing interaction with GSK-3 followed by enhanced phosphorylation of N by GSK-3.

Because the Axin-GSK-3 binding structure is well-determined (14, 22) , we next compared the binding site of Axin2 and N with that in wild type (wt) and mutants GSK-3. Consistently, Y216 and V267/E268 in GSK-3 were critical for Axin2 binding (Fig.   S2B ), and N shared those binding sites in GSK-3 ( Fig. 2A) , indicating that N utilizes a GSK-3 binding mode similar to that of Axin. Previously, we reported that antihelminthic niclosamide interacts with GSK-3 and inhibits Axin-GSK3 binding, resulting in attenuation of Wnt signaling and EMT in APC-mutated colorectal cancer (19) . 8 Niclosamide also inhibits viral replication of SARS-CoV-1 (23) although the molecular mechanism of action (MoA) of niclosamide on SARS-CoV is unclear. Given the similar binding modes of N and Axin to GSK-3, we next performed immunoprecipitation assay with increasing doses of niclosamide. Indeed, niclosamide inhibited Axin2 or N binding to GSK-3 in a dose-dependent manner (Fig. 2B) . While N-GSK-3 interaction was maintained at 2 μM concentration of niclosamide, Axin2 binding to GSK-3 was largely abolished at the same concentration. These results suggest that N harbors stronger binding affinity to GSK-3 than does Axin2, and explain the modest therapeutic potential of niclosamide in SARS-CoV-2 in vitro (24) . In turn, these results suggest the possibility that N and Axin2 compete in GSK-3 binding. To test this, we next utilized split GFP systems (25) . For the split GFP assay, superfolder GFP1-10 (amino acids 1-214) and GFP11 (amino acid 214-230) fragments were fused to GSK-3 and N, respectively. Co-transfection of GSK3-GFP1-10 and N-GFP11 gave rise to green fluorescence via direct interaction between GSK-3 and N, and fluorescence was largely decreased by the overexpression of Axin2, indicating that N and Axin compete in similar binding regions of GSK-3 (Fig. 2C ).

Because Axin directly suppresses kinase activity of GSK-3 via GID, thus regulating various signaling pathways (11, 12) , we next examined the role of N in GSK-3 kinase activity and the subsequent Wnt/EMT signaling pathway. Surprisingly, overexpression of N or N-GID mutant did not affect endogenous GSK-3 kinase activity in 293 cells ( Fig   3A) . Furthermore, overexpression of N or N-GID mutant did not affect GSK-3 abundance or phosphorylation status on Ser9 and Y216 (Fig. 3B ). As well-known downstream of β-catenin, EMT-inducer Snail abundance, TCF/LEF transcriptional, and E-cadherin promoter activity were unchanged (Fig. 3C) . These results indicate that N utilizes GSK-3 for its phosphorylation but does not affect GSK-3 kinase activity and subsequent signaling pathways, probably due to rapid dissociation following phosphorylation.

While human coronaviruses HKU1, OC43, 229E, and NL63 typically cause upper respiratory infection with relatively minor symptoms, SARS-CoV and SARS-CoV-2 in the sarbecovirus lineage of beta-coronavirus replicate in the lower respiratory tract and cause severe pneumonia (26) . To understand the role of GID in the evolution of coronavirus, we next analyzed GID and SR-rich phosphorylation motif among various coronaviruses (Fig. 4A ). Intriguingly, we found several differences in N-GID of sarbecovirus lineage SARS-CoV-2 as compared to other coronaviruses (27) . First, sarbecovirus lineage N harbors a typical GID, similar to endogenous GSK-3 binding proteins, as mentioned earlier. Second, N of sarbecovirus contained a CDK1 phosphorylation site (S206) with a conserved pSPxK/R motif that may serve to primed phosphorylation of GSK-3 (28) . Third, N of sarbecovirus has a Gly-rich flexible linker between GID and SR-rich phosphorylation domain. Based on these observations, we hypothesize that CDK1 serves to primed phosphorylation of GSK-3 and that Gly-rich linker facilitates phosphorylation of N. To test this hypothesis, we generated N expression vectors with substitution either of CDK1 phosphorylation site (S206A) or 10 GNGG linker to DEIA (N-DEIA), corresponding to sequences in HKU1 coronavirus.

Then, we transfected the expression vectors and examined the protein abundance, GSK-3 binding and phosphorylation status of N. Through western blot and immunoprecipitation analysis, we found a similar protein abundance and binding capacity to GSK-3 of N and mutant N expression vectors (Fig. 4B) . Interestingly, mutation of the CDK1 phosphorylation site (N-S206A) and of Gly-rich linker (N-DEIA) decreased phosphorylation status compared to ancestral N in phos-tag analysis (Fig.   4C ). These results indicate that emergence of CDK1 and Gly-rich linker together with GID in sarbecovirus lineage play an important role in enhanced phosphorylation of N.

Given the clinical difference between the sarbecovirus lineage of beta-coronavirus and other coronaviruses, we next compared N abundance in those coronaviruses.

Transfecting N of SARS-CoV-2, 229E, OC43, and HKU1 strains, we found significantly increased N abundance in SARS-CoV-2 compared to N in other coronaviruses ( Fig.   5A ). Only N of 229E revealed detectable binding to GSK-3. To further determine the role of GSK-3 and GID, we next generated N-229E expression vectors having a CDK1primed phosphorylation site, Gly-rich linker, and GID corresponding to those of sequences in N of SARS-CoV-2. Comparing N of 229E to those mutants, we found that introduction of primed phosphorylation and Gly-rich linker significantly increased phosphorylation as well protein abundance (about 2-fold) of N-229E (Fig. 5B) . Notably, N-229E showed at least 7 bands in phos-tag gel analysis, indicating that N of most 11 coronavirus is hyper-phosphorylated in SR-rich motif (29) . These results indicate that N of sarbecovirus lineage has evolved to become hyper-phosphorylated with GID, CDK-1 mediated primed phosphorylation, and flexible linker between GID and SR-rich motif.

Because SARS-CoV-2 continuously evolves through mutational changes, there are 

GSK-3 is highly expressed endogenously in mammals and is an exceptional kinase inactivated by exogenous signaling, such as by insulin and Wnt (11, 12) . Priming phosphorylation by other many kinases allows strong (500-to 1,000 fold) preference of GSK-3 substrates which have multiple and serial phosphorylation sites by GSK-3, including EMT-inducer Snail and β-catenin (30, 31) . The importance of GSK-3 has been extensively confirmed in human diseases, including Alzheimer's, metabolic diseases, and cancer (11, 12) . Notably, many viruses or bacterial genes directly interact with and utilize endogenous GSK-3 for entry, replication and latency (32) . observations that GSK-3 phosphorylates N and its phosphorylation is critically important for viral RNA binding (6, 34, 35) , we wondered about the role of GSK-3mediated phosphorylation of N during SARS-CoV-2 evolution because the GSK-3 comprises a key kinase involving many endogenous biological events (11, 12) . We found the GID amino acid sequence in N of Sarbecovirus lineage consists of L/FxxxL/AxxRL. Axin binds to GSK-3 via GID, the binding being critically important for phosphorylation and protein abundance of Axin (21) . However, mutation of hydrophobic residues in N-GID, which plays critical role in GSK-3 binding, largely abolished the interaction with GSK-3 without affecting N protein abundance. Our observations suggest that N, unlike GSK-3 scaffolding proteins, is highly phosphorylated by GSK-3 followed by rapid dissociation. Since the phosphorylation of N is critically important for self-oligomerization, multivalent RNA-protein complex formation, and subsequent liquid-liquid separation with RNA condensates formation (35, 36) , our observations suggest that GSK-3 is mainly involved in viral RNA processing within the replication transcription complex (RTC). The phosphorylation status of N protein in SARS-CoV-2 virion and existence of endogenous protein phosphatase are interesting issues raised by this study.

While SARS-CoV-2 is currently evolving increased transmissibility, the functional importance of mutations in the variants is technically challenging. Recent observation has revealed that S202R in Lota and R203M in Delta variant provide 166-fold and 51fold higher viral production, respectively (10) . In this study, we showed that pS206 priming phosphorylation by CDK1 and Gly-rich linker located between GID and SRrich motif enhance phosphorylation of N. Given the multiple bands in N of 229E strain, N of SARS-CoV-2 may have multiple phosphorylation sites in SR-rich motif.

Interestingly, emerging variants have mutations near the primed phosphorylation site.

Notably, R203K/G204R, found in a highly transmissible Omicron variant, allows greater phosphorylation and protein abundance than N of ancestral and other variants.

Because more than fifteen Ser/Thr residues exist in SR-rich motif, our results indicate that N of Omicron gains further phosphorylation via R203K/G204R mutation. Taken together, our observations suggest that enhanced phosphorylation and increased protein abundance of N as well as mutations of Spike may provide a selective advantage during the mutational evolution of SARS-CoV-2. Further study is needed to elucidate the importance of N phosphorylation in the emergence and evolution of SARS-CoV-2.

Previously, we observed that antiheminthic niclosamide disrupts Axin-GSK3 interaction, providing a repositioned therapeutic for colon cancer and familial adenomatosis coli (20) . While niclosamide is consistently effective in disrupting Axin2-GSK-3 binding, an at least 5-fold concentration of niclosamide was required for disruption of N-GSK-3 interaction in our hands, indicating that N has a stronger interaction with GSK-3 than that of Axin2. Conversely, our observations provide an MoA of niclosamide on SARS-CoV replication and N expression, at least in part (23), with implications for the clinical trial of niclosamide for SARS-CoV-2 (37). Although GSK-3 kinase inhibitors can be a therapeutic target for SARS-CoV-2, the endogenous abundance of GSK-3 along with its diverse physiological roles largely limit the 16 therapeutic potential of GSK-3 inhibitors for viral diseases. Thus, further study is required regarding the protein-protein interaction of N-GSK-3 as a therapeutic target for SARS-CoV-2 infection in human.

The 293 cells obtained from ATCC were routinely cultured in DMEM medium 

For the western blot analyses, protein extracts were prepared in Triton X-100 lysis buffer. Phosphorylation status of N protein was determined by anti-flag antibody and mobility shift on a Phos-tag gel (Wako) as described previously (38) .

For immunoprecipitation analysis, whole cell Triton X-100 lysates were incubated with Flag-M2 agarose (Sigma) and washed with lysis buffer three times. The recovered proteins were resolved by SDS-PAGE and subjected to immunoblot analysis. For immunofluorescence study, the cells were washed twice with ice-cold PBS and incubated for 15 min at room temperature with 3% formaldehyde in PBS. The cells were permeabilized with 0.5% Triton X-100 for 5 min and then blocked for 1 h in PBS containing 3% bovine serum albumin followed by incubation with primary antibody over night at 4 o C. Cells were then washed three times with PBS containing 0.1% Tween 20 followed by incubation with anti-mouse-Alexa Fluor-488 (for green) or antirabbit-Alexa Fluor-594 (for red) secondary antibody. Cellular fluorescence was monitored using confocal microscopy (Zeiss).

For TCF/LEF and E-cadherin reporter assay, the cells were transfected with 50 ng of the Super-Top or E-cad(-108)-Luc reporter vector (30, 39) and 1 ng of pSV40-Renilla expression vector in combination with N or N-mutant as indicated. Luciferase and renilla activities were measured using the dual-luciferase reporter system kit (Promega), and the luciferase activity was normalized with renilla activity. The results are expressed as the averages of the ratios of the reporter activities from triplicate experiments.

For split superfolder GFP assay, the GFP1-10 and GFP11 constructs were kindly provided by Professor Hye Yoon Park at Seoul National University. The GFP1-10 fragment was fused into N-terminus of GSK-3 and GFP11 was fused into C-terminus of N. The 293 cells were co-transfected with split GFP vectors, and fluorescence intensity was determined by 5 random areas with the same exposure, followed by ImageJ analysis. 

P15130 Alpha

HCoV-NL63 Q6Q1R8 Alpha 

2021) N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection

Molecular interactions in the assembly of coronaviruses

The SARS coronavirus nucleocapsid protein--forms and functions

Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 longterm care facilities (VIVALDI): a prospective cohort study

Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication

Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization

Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription

Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition

Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles

The renaissance of GSK3

GSK-3: tricks of the trade for a multi-tasking kinase

Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin

Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex

Involvement of the residues of GSKIP, AxinGID, and FRATtide in their binding with GSK3beta to unravel a novel C-terminal scaffold-binding region

WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β

A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells

Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen

Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction

Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3

Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability

of the Axin and Frat binding region of glycogen synthase kinase-3

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide

Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells

Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein

The trinity of COVID-19: immunity, inflammation and intervention

Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review

The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells

Identification of phosphorylation sites in the nucleocapsid protein (N protein) of SARScoronavirus

Wnt-dependent regulation of the E-cadherin repressor snail

GSK-3: Functional Insights from

GSK-3-associated signaling is crucial to virus infection of cells

Helicobacter pylori CagA promotes Snailmediated epithelial-mesenchymal transition by reducing GSK-3 activity

Mass spectroscopic characterization of the coronavirus infectious bronchitis virus 24 nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance

The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein

Phosphorylation modulates liquid-liquid phase separation of the SARS-CoV-2 N protein

Niclosamide for Covid-19: bridging the gap

Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner

A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition

The authors declare no competing financial interest.